Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781025 · ClinicalTrials.gov registry record
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 42
- Enrollment target
NCT02781025 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 42 participants.
The verdict
NCT02781025 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the feasibility of using novel decellularized tissue matrices to isolate and culture circulating tumor cells (CTCs) collected from patients with metastatic solid tumor malignancies.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02781025
The ClinicalTrials.gov registry entry for NCT02781025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT02781025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02781025 about?
NCT02781025 is a clinical study titled "Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease". The purpose of this study is to investigate the feasibility of using novel decellularized tissue matrices to isolate and culture circulating tumor cells (CTCs) collected from patients with metastatic solid tumor malignancies.
What is the current status of trial NCT02781025?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2016-04. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT02781025?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT02781025?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.